Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
QR678 Neo
- Development stage
- Unknown
- Lead developer
- The Esthetic Clinics
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Administration
- Intradermal
01
Overview
QR678 Neo is a patented, first-in-class biologic formulation developed by The Esthetic Clinics for the treatment of various forms of hair loss and alopecia. It consists of a proprietary combination of six biomimetic polypeptides and growth factors that mimic those naturally present in the human scalp. The treatment works by stimulating hair follicles, specifically by shortening the telogen (shedding) phase and prolonging the anagen (growth) phase of the hair cycle. Administered via intradermal injections, QR678 Neo has received Indian FDA approval and holds patents in both the United States and India. It is used to treat androgenetic alopecia, female pattern hair loss, telogen effluvium, and chemotherapy-induced alopecia. The 'Neo' version represents an advanced formulation offering improved stability and a longer shelf life compared to the original QR678.
- Brand names
- QR678 NeoQR-678 NeoQR 678 Neo
- Other names
- QR678QR-678QR 678
02
Targets
FGFR2 (Keratinocyte growth factor receptor)IGF-1R (Insulin-like growth factor 1 receptor)VEGFR (VEGFR family)
Beyond the preview
Go deeper on QR678 Neo.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on QR678 Neo.